Demonstrating Value, Driving Down Costs: Comparative Effectiveness Research & Radiology

Doing more with less. It is the mantra of healthcare today, as providers across the U.S. strive to offer better care at a reduced cost. In this environment, the necessity of comparative effectiveness research becomes increasingly apparent. Can challenges specific to radiology be overcome to cogently conduct comparative effectiveness research, making practice more patient-centered in the process?

Comparative effectiveness research (CER) has secured its spot in analyzing and evaluating the performance of procedures, diagnostic tests, and treatments in relation to one another. It aims to identify the most safe, effective, and in some instances cost-effective approach out of a variety of procedures and strategies, thereby eliminating those that do not better patient management or outcomes. CER also strives to improve the decision making of the multiple stakeholders involved in healthcare—providers, patients, payers, researchers, policymakers, and manufacturers—regarding industry improvement both on an individual and population basis.

Complexity and challenges behind cogent CER

CER holds much promise in bettering radiology by justifying the value of imaging. This specialized research links the path from diagnosis to patient outcome, proving to patients that their scans and other procedures are purposeful—or not.

Despite the benefits of CER, execution remains a challenge. “The outcomes of a comparison study between different imaging strategies may vary depending on patient populations,” says James Rawson, MD, FACR, of Georgia Regents University Augusta. According to Rawson, small subpopulations that benefit from clinical services must be identified in CER.

“To demonstrate radiology’s value and possibly head-off further reimbursement cuts to the specialty, CER has to show a linkage between the actual radiology intervention and the outcome for the patient,” adds Rawson.

That link is another challenge, says Alfred Berg, MD, MPH, of the University of Washington School of Medicine in Seattle and member of the Patient Centered Outcomes Research Institute (PCORI) Methodology Committee. Based in Washington, D.C., PCORI aims to improve healthcare decision making and improve healthcare delivery and outcomes through the production and promotion of high quality, evidence-based information. To date, PCORI has approved 279 awards totaling more than $464.4 million dollars to fund patient-centered CER research projects. “Interventional radiology is at the core of a lot of issues related to CER. It’s often easy to have research that shows that one practice is better than not doing anything, but there is a struggle to find research that directly compares two different modes,” says Berg. 

“It’s hard to find research for CER that examines different classes of treatment,” Berg continues. “While a series of reports is needed to create questions that make this type of research possible, the demand for time, patient resources, and funding makes it more difficult. However, this is the kind of information we need, especially in radiology.”

Another obstacle to conducting CER in radiology is rapidly changing technology. Large-scale clinical trials attempt to compare mature diagnostic imaging techniques, but their constant evolution makes this task difficult, says Rawson.

Workflow and exam ordering is another major challenge with radiology versus other medical specialties. While the focus of CER research in radiology is on radiologic exams, radiologists do not order them. Consequently, the ordering behavior of referring physicians needs to change, explains Rawson. “If we want to alter behavior, we need to look at all of the things that can be done to ensure that the desired behavior is the easiest pathway for referring physicians,” he remarks.

A study published in the British Medical Journal by Bessen et al exemplifies this issue. Though the Ottawa ankle rules (OAR) have been widely accepted as a highly accurate clinical decision tool in the identification of high-risk ankle injuries that require CT, the application of these rules in emergency departments varied considerably. The study’s authors discovered that a multifaceted change strategy that included education, use of updated problem specific radiography request forms, reminders, audit and feedback, and “gatekeeping” by radiographers bettered clinician adoption of the OAR.

“Checklists, computerized order entry sets, clinical pathways, and decision support software are all ways to make standardization of care for best practice the easiest practice,” emphasizes Rawson.

But clinicians may be wary of changing their ways in light of a CER study’s findings, says Adam Elshaug, PhD, MPH, of the University of Sydney in Australia. Concerns that the population and conditions of the study do not reflect real-world medicine often impede behavioral modifications.

“While CER is shedding important light on both the underuse of valuable services and the overuse of inappropriate care, there can remain a grey zone of uncertainty in between,” says Elshaug. “To overcome this requires a commitment to iteratively improve CER study designs so that questions of uncertainty can be resolved. All stakeholders have a legitimate stake, and responsibility, to achieve this.”

The power of partnership in study design

Though conducting CER in radiology can be trying, the successes shows its viability. Rawson cites the example of the National Oncology PET Registry (NOPR) established with Medicare under a coverage with an evidence-development pathway. “If a procedure is listed on the NOPR, Medicare would pay for it,” says Rawson. “A referring physician would have to submit patient information to Medicare before and after a scan. The information gathered showed how often PET scans changed treatment plans for patients. There was such a high percentage of change that many tumors were added to the list for coverage approval.”

Also showing success are two recent studies published in JAMA Internal Medicine by Wernli et al and Stout et al utilizing differing CER methods to investigate trends in breast MRI use against guideline criteria for appropriateness. “Conducted in two different patient populations, the studies’ findings were remarkably consistent,” explains Elshaug. “They found that breast MRI was both overused in women not meeting guideline criteria and underused in those who could derive greatest benefit. This hints at the real potential of CER by articulating patient sub-group experiences for a greater understanding of who will benefit from certain episodes of care and those who are less likely to benefit.”

Well-designed CER studies should purport research that measures a patient outcome, rather than findings from a short-term comparison between imaging modalities. Upon the implementation of these studies, all of the stakeholders should be involved in the planning processes, Rawson contends. Barriers also need to be lowered so that updated processes are easier to adopt. This may be accomplished through the distribution of evidence-based information to patients, clinicians, and other decision makers.

“CER might elucidate low-value applications of radiology as well as high-value applications,” says Elshaug. “Understanding this bidirectional potential is in everyone’s interests, from payers to providers to patients, as it allows for an increase in optimal, efficient care.”

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.